⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL78898 | 1.00 | — | — | |
| SCHEMBL22129611 | 1.00 | — | — | |
| SCHEMBL2994808 | 0.95 | ALDH1A1 (0.80) | — | |
| SCHEMBL597999 | 0.94 | — | — | |
| SCHEMBL1004477 | 0.94 | — | — | |
| SCHEMBL18075 | 0.94 | — | — | |
| SCHEMBL20193393 | 0.89 | ALDH1A1 (0.89) | — | |
| SCHEMBL3767440 | 0.89 | ALDH1A1 (0.89) | — | |
| SCHEMBL21841873 | 0.89 | ALDH1A1 (0.89) | — | |
| SCHEMBL18897676 | 0.89 | ALDH1A1 (0.89) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 920 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4301736-B1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | LEAD DISCOVERY CENTER GMBH (DE) | 2025-10-08 | — | — | EP | claimed |
| US-20250223285-A1 | NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS | JACOBIO PHARMACEUTICALS CO LTD (CN) | 2025-07-10 | — | — | US | claimed |
| US-20240415819-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | QLi5 Therapeutics AG (DE) | 2024-12-19 | — | — | US | claimed |
| WO-2024083223-A1 | MACROCYCLIC COMPOUNDS AND MEDICAL USE THEREOF | 正大天晴药业集团股份有限公司 | 2024-04-25 | — | — | WO | claimed |
| WO-2024059745-A2 | N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTAGONISTS AND USES THEREOF | BEXSON BIOMEDICAL, INC. (US) | 2024-03-21 | — | — | WO | claimed |
| EP-4155296-A1 | MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS | Lead Discovery Center GmbH (DE) | 2023-03-29 | — | — | EP | claimed |
| EP-3753936-A1 | PYRIDONE DERIVATIVE, COMPOSITION THEREOF AND APPLICATION THEREOF AS ANTI-INFLUENZA DRUG | Jiangxi Caishi Pharmaceutical Technology Co., Ltd. (CN) | 2020-12-23 | — | — | EP | claimed |
| EP-3642264-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | Momentive Performance Materials Inc. (US) | 2020-04-29 | — | — | EP | claimed |
| US-10385210-B2 | Curable silicone composition and applications and uses thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-08-20 | — | — | US | claimed |
| WO-2019141179-A1 | PYRIDONE DERIVATIVE, COMPOSITION THEREOF AND APPLICATION THEREOF AS ANTI-INFLUENZA DRUG | 银杏树药业(苏州)有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-1998012156-A1 | COMBINATORIAL APPROACH FOR GENERATING NOVEL COORDINATION COMPLEXES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-03-26 | — | — | WO | claimed |
| EP-0502839-B1 | Functionalized polymers | MONSANTO CO (US) | 1997-07-09 | — | — | EP | claimed |
| EP-0714302-A4 | THERAPEUTIC COMPOUNDS | CELL THERAPEUTICS INC (US) | 1996-10-09 | — | — | EP | claimed |
| EP-0714302-A1 | THERAPEUTIC COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1996-06-05 | — | — | EP | claimed |
| WO-1994024133-A1 | RING-SUBSTITUTED CELL SIGNALING INHIBITORS | CELL THERAPEUTICS, INC. (US) | 1994-10-27 | — | — | WO | claimed |
| WO-1994022449-A1 | THERAPEUTIC COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-10-13 | — | — | WO | claimed |
| US-5294675-A | A-C copoly;hydroformylation | MONSANTO COMPANY (US) | 1994-03-15 | — | — | US | claimed |
| US-5232989-A | Hydroformylation of polyoefins, reduction to hydroxyl groups, reacting with diisocyanate | MONSANTO COMPANY (US) | 1993-08-03 | — | — | US | claimed |
| EP-0073100-B1 | BETA-LACTAM COMPOUNDS, THEIR PREPARATION AND THEIR USE | BEECHAM GROUP PLC (GB) | 1985-10-02 | — | — | EP | claimed |
| EP-0043446-B1 | INTERMEDIATES OF 13-THIA-PROSTAGLANDIN, THEIR PREPARATION AND APPLICATION TO THE SYNTHESIS OF 13-THIA-PROSTAGLANDIN DERIVATIVES | MERCK PATENT GmbH (DE) | 1984-02-22 | — | — | EP | claimed |